Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHFSNASDAQ:CVRXNASDAQ:NDRANASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHFSNuwellis$0.22-7.3%$4.79$4.86▼$37.50$1.33M1.55467,323 shs1.90 million shsCVRXCVRx$6.04+2.7%$6.43$4.30▼$18.55$153.31M1.23317,413 shs128,668 shsNDRAENDRA Life Sciences$3.41-2.8%$3.84$2.90▼$179.20$2.59M-0.18141,465 shs14,553 shsSKINBeauty Health$2.16+13.1%$1.53$0.78▼$2.24$240.65M1.22973,269 shs1.31 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHFSNuwellis-7.28%-25.49%-74.37%-76.99%-95.62%CVRXCVRx+2.72%-0.49%-8.76%-53.47%-48.42%NDRAENDRA Life Sciences-2.85%-1.45%-0.87%-16.63%-99.96%SKINBeauty Health+13.09%+12.50%+31.31%+45.95%+17.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHFSNuwellisN/AN/AN/AN/AN/AN/AN/AN/ACVRXCVRx2.7269 of 5 stars3.41.00.00.02.34.20.6NDRAENDRA Life Sciences3.1535 of 5 stars3.55.00.00.02.20.01.3SKINBeauty Health0.3903 of 5 stars0.80.00.00.02.83.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHFSNuwellis 0.00N/AN/AN/ACVRXCVRx 2.71Moderate Buy$14.50140.07% UpsideNDRAENDRA Life Sciences 3.00Buy$50.001,366.28% UpsideSKINBeauty Health 1.67Reduce$1.42-34.41% DownsideCurrent Analyst Ratings BreakdownLatest NDRA, CHFS, CVRX, and SKIN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025CVRXCVRxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$20.00 ➝ $12.005/9/2025CVRXCVRxJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$15.00 ➝ $7.005/5/2025SKINBeauty HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.50 ➝ $1.254/21/2025NDRAENDRA Life SciencesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$75.00 ➝ $50.004/8/2025CVRXCVRxLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.00 ➝ $14.004/8/2025CVRXCVRxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$23.00 ➝ $18.00(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHFSNuwellis$5.51M0.24N/AN/A$12.79 per share0.02CVRXCVRx$51.29M3.07N/AN/A$2.93 per share2.06NDRAENDRA Life SciencesN/AN/AN/AN/A$4.77 per shareN/ASKINBeauty Health$334.30M0.81$0.07 per share30.21$0.41 per share5.27Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHFSNuwellis-$18.11M-$279.28N/AN/AN/A-254.26%-173.61%-131.01%N/ACVRXCVRx-$59.97M-$2.18N/AN/AN/A-97.49%-79.04%-42.37%8/4/2025 (Estimated)NDRAENDRA Life Sciences-$11.51M-$172.04N/AN/AN/AN/A-140.96%-106.14%8/13/2025 (Estimated)SKINBeauty Health-$29.10M-$0.41N/AN/AN/A-11.94%-67.91%-5.56%8/6/2025 (Estimated)Latest NDRA, CHFS, CVRX, and SKIN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025CVRXCVRx-$0.56-$0.53+$0.03-$0.53$14.68 million$12.35 million5/8/2025Q1 2025SKINBeauty Health-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHFSNuwellisN/AN/AN/AN/AN/ACVRXCVRxN/AN/AN/AN/AN/ANDRAENDRA Life SciencesN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHFSNuwellisN/A6.875.97CVRXCVRx0.7114.8213.45NDRAENDRA Life SciencesN/A3.853.85SKINBeauty Health12.017.476.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHFSNuwellis65.06%CVRXCVRx75.27%NDRAENDRA Life Sciences1.19%SKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipCHFSNuwellis0.60%CVRXCVRx18.90%NDRAENDRA Life Sciences0.04%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHFSNuwellis666.04 millionN/ANot OptionableCVRXCVRx16026.07 million21.15 millionOptionableNDRAENDRA Life Sciences20740,000738,000Not OptionableSKINBeauty Health1,030125.99 million74.34 millionOptionableNDRA, CHFS, CVRX, and SKIN HeadlinesRecent News About These CompaniesPerimenopause and your skin: 7 skincare tweaks to keep your skin glowing and healthyJuly 1 at 12:27 PM | moneycontrol.comShefali Jariwala’s Tragedy Exposes Hidden Dangers Of The ₹8000-Crore Beauty Supplement CrazeJuly 1 at 12:27 PM | msn.comThe 18 Best New Beauty Products That Launched in JuneJuly 1 at 12:27 PM | wmagazine.comWDespite Fast-paced Momentum, Beauty Health (SKIN) Is Still a Bargain StockJuly 1 at 9:50 AM | zacks.comShoppers are Racing to Ulta for This New 'One of a Kind' Hydrating Beauty Item That Reduces RednessJuly 1 at 7:27 AM | msn.com5 tips for building a healthy skincare routine for tweens and teensJuly 1 at 2:25 AM | theweek.comTAre IV Glutathione drips safe for beauty treatments? What you need to knowJune 30 at 4:23 PM | theweek.inTVitamin C Promotes Skin Cell Growth to Keep Skin Healthy and Prevent AgingJune 30 at 4:23 PM | msn.comThis K-Beauty Skin Care Hack Keeps My Skin Moisturized Every NightJune 30 at 4:23 PM | msn.comFive new skincare and beauty products we swear by for a healthy glam look!June 30 at 2:31 AM | msn.comThe 10 Best Peptide Serums for Firmer, More Hydrated SkinJune 27, 2025 | msn.comAre Estrogen Creams The Answer To Age-Related Skin Shifts? Dermatologists Reveal The Truth.June 27, 2025 | msn.comHere's why neem is great for your skinJune 27, 2025 | newsbytesapp.comNPlexus Worldwide unveils new Skin Health System line, aims to quintuple skincare revenueJune 27, 2025 | bizjournals.comAFRICAN SHEA BUTTER IS EVERYTHING | Hair, Skin, and Health benefits!June 27, 2025 | msn.comElaborate Skin Care Routines Can Cause Teens More Harm Than GoodJune 27, 2025 | medscape.comMWhat Does Your Skin Really Need? How to Achieve Truly Healthy SkinJune 27, 2025 | healthline.comHAuthor Carley Fortune’s Self-Care and Beauty SecretsJune 26, 2025 | msn.comWatchdog warning over health risks of skin-lightening beauty trendJune 26, 2025 | msn.comShould I Be Putting Microalgae on My Skin?June 26, 2025 | nymag.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNDRA, CHFS, CVRX, and SKIN Company DescriptionsNuwellis NASDAQ:CHFSNuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.CVRx NASDAQ:CVRX$6.04 +0.16 (+2.72%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$5.90 -0.14 (-2.30%) As of 07/1/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.ENDRA Life Sciences NASDAQ:NDRA$3.41 -0.10 (-2.85%) Closing price 07/1/2025 03:59 PM EasternExtended Trading$3.42 +0.00 (+0.15%) As of 07/1/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.Beauty Health NASDAQ:SKIN$2.16 +0.25 (+13.09%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$2.20 +0.04 (+2.08%) As of 07/1/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
